Behbahani Ali
Arcellx, Inc. · Director
Behbahani Ali is listed in filings as Director at Arcellx, Inc.. This profile follows SEC Form 4 activity through Apr 28, 2026, including sale activity. Recent filings connect the profile to Arcellx, Inc. (ACLX), Korro Bio, Inc. (KRRO), Adaptimmune Therapeutics plc (ADAPY), and Monte Rosa Therapeutics, Inc. (GLUE). The current snapshot covers public activity from Jun 12, 2024 to Apr 28, 2026. Reported amounts are shown as $584.2K to $411.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $176k14.7M shares | SellAug 18, 2025 | $0.012 | $0.028 |